- Home
- DRRX vs ACXP Comparison
DRRX vs ACXP Comparison
Compare DRRX & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- ACXP
- Stock Information
- Founded
- DRRX 1998
- ACXP 2017
- Country
- DRRX United States
- ACXP United States
- Employees
- DRRX N/A
- ACXP N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- DRRX Health Care
- ACXP Health Care
- Exchange
- DRRX Nasdaq
- ACXP Nasdaq
- Market Cap
- DRRX 26.3M
- ACXP 31.4M
- IPO Year
- DRRX 2000
- ACXP 2021
- Fundamental
- Price
- DRRX $0.75
- ACXP $0.77
- Analyst Decision
- DRRX Buy
- ACXP Strong Buy
- Analyst Count
- DRRX 2
- ACXP 1
- Target Price
- DRRX $5.00
- ACXP $12.00
- AVG Volume (30 Days)
- DRRX 67.3K
- ACXP 479.2K
- Earning Date
- DRRX 03-26-2025
- ACXP 03-14-2025
- Dividend Yield
- DRRX N/A
- ACXP N/A
- EPS Growth
- DRRX N/A
- ACXP N/A
- EPS
- DRRX N/A
- ACXP N/A
- Revenue
- DRRX $8,594,000.00
- ACXP N/A
- Revenue This Year
- DRRX $54.32
- ACXP N/A
- Revenue Next Year
- DRRX N/A
- ACXP N/A
- P/E Ratio
- DRRX N/A
- ACXP N/A
- Revenue Growth
- DRRX N/A
- ACXP N/A
- 52 Week Low
- DRRX $0.68
- ACXP $0.68
- 52 Week High
- DRRX $1.88
- ACXP $3.35
- Technical
- Relative Strength Index (RSI)
- DRRX 38.86
- ACXP 45.19
- Support Level
- DRRX $0.71
- ACXP $0.70
- Resistance Level
- DRRX $0.85
- ACXP $0.87
- Average True Range (ATR)
- DRRX 0.06
- ACXP 0.06
- MACD
- DRRX -0.01
- ACXP 0.01
- Stochastic Oscillator
- DRRX 26.38
- ACXP 34.83
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.